Merck (MRK) and Schering-Plough (SGP) Lower After Vytorin Fails To Help Artery Damage
Tweet Send to a Friend
Shares of Merck (NYSE: MRK) and Schering-Plough (NYSE: SGP) are under pressure this morning following a study which showed cholesterol ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


